Assessment of hepatic blood flow using continuous infusion of high clearance drugs
Open Access
- 1 May 1998
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 45 (5) , 463-469
- https://doi.org/10.1046/j.1365-2125.1998.00711.x
Abstract
Aims To provide methods for the translation of the concentration-time profile of highly cleared marker compounds into the underlying clearance and hepatic blood flow profile. Methods Continuous infusion of indocyanine green or sorbitol was used to assess the effect of the hepatic blood flow modifiers exercise, somatostatin and octreotide. Three distinct methods are described for the translation of concentration into flow: 1. assuming successive phases of constant clearance 2. point to point estimation of clearance using estimates of concentration change 3. using a parametric description of the flow profile in combination with the differential equations describing the change in marker concentrations. Results The marker compound concentration profiles are adequately described using the different methods. Exercise results in a decrease in hepatic blood flow of about 80%. Somatostatin and octreotide elicit an indistinguishable hepatic blood flow decrease from 1.49 to 1.07 l min−1. Return to baseline takes much longer for octreotide (half-life 126±104 min) than for somatostatin (half-life 4.29±3.55 min). Conclusions Translation of concentration profiles into clearance profiles is possible making continuous assessment of hepatic blood flow feasible.Keywords
This publication has 13 references indexed in Scilit:
- Estimating impossible curves using NONMEMBritish Journal of Clinical Pharmacology, 1996
- Influence of 1-Desamino-8-d-Vasopressin on Endogenous Fibrinolysis, Haemodynamics and Liver Blood Flow in Healthy SubjectsClinical Science, 1994
- Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.British Journal of Clinical Pharmacology, 1991
- Clinical Significance of Pharmacokinetic Models of Hepatic EliminationClinical Pharmacokinetics, 1990
- The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.1986
- The Influence of a Long-Acting Somatostatin Analogue on Splanchnic Haemodynamics and Metabolism in Healthy Subjects and Patients with Liver CirrhosisScandinavian Journal of Gastroenterology, 1986
- Physiological and pharmacological variability in estimated hepatic blood flow in man.Published by Wiley ,1981
- Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjectsGastroenterology, 1981
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.Journal of Clinical Investigation, 1977